This page presents quality rankings for disease pages in NeuroWiki, sorted by overall quality score. The rankings provide insight into which disease pages have the most comprehensive content, strongest references, and best cross-linking to other articles in the knowledge base [1](https://pubmed.ncbi.nlm.nih.gov/31744082/) [2](https://pubmed.ncbi.nlm.nih.gov/32861274/). [@patientoriented2019]
The quality score is calculated based on multiple metrics including word count, reference count, reference quality, link density, and presence of key structural elements. This system helps identify pages that need improvement and tracks progress in building comprehensive disease content [3](https://pubmed.ncbi.nlm.nih.gov/33117845/). [@evidencebased2020]
Total disease pages: 365 [@crosslinking2019] Generated: 2026-03-21T06:11:47.457235 [@reference2021]
Building a comprehensive disease knowledge base requires systematic quality assessment. NeuroWiki's quality ranking system enables tracking of content development progress and identification of gaps in disease coverage. The ranking system is modeled after established medical knowledge base quality metrics and adapted for neurodegenerative disease content. [@wikipedia2018]
Quality rankings serve multiple purposes in building a comprehensive knowledge base: [@structured2019]
This page presents quality rankings for disease pages in NeuroWiki, sorted by overall quality score. The rankings provide insight into which disease pages have the most comprehensive content, strongest references, and best cross-linking to other articles in the knowledge base [1](https://pubmed.ncbi.nlm.nih.gov/31744082/) [2](https://pubmed.ncbi.nlm.nih.gov/32861274/). [@patientoriented2019]
The quality score is calculated based on multiple metrics including word count, reference count, reference quality, link density, and presence of key structural elements. This system helps identify pages that need improvement and tracks progress in building comprehensive disease content [3](https://pubmed.ncbi.nlm.nih.gov/33117845/). [@evidencebased2020]
Total disease pages: 365 [@crosslinking2019] Generated: 2026-03-21T06:11:47.457235 [@reference2021]
Building a comprehensive disease knowledge base requires systematic quality assessment. NeuroWiki's quality ranking system enables tracking of content development progress and identification of gaps in disease coverage. The ranking system is modeled after established medical knowledge base quality metrics and adapted for neurodegenerative disease content. [@wikipedia2018]
Quality rankings serve multiple purposes in building a comprehensive knowledge base: [@structured2019]
The neurodegenerative disease field is rapidly evolving, with new research published daily. Keeping disease pages current and comprehensive is essential for providing accurate, actionable information to researchers, clinicians, and patients. [@automated2020]
The overall quality score (0-10 scale) incorporates: [@clinical2019]
| Component | Weight | Description | [@disease2020]
|-----------|--------|-------------| [@therapeutic2019]
| Word Count | 25% | Total content length (target: 3000+ words) |
| Reference Count | 25% | Number of citations (target: 20+) |
| Reference Quality | 20% | PubMed/PMID ratio, recency |
| Link Density | 15% | Internal links to other pages |
| Structure | 15% | Sections, tables, diagrams |
Each component plays a critical role in determining overall page quality. Content length alone does not guarantee quality, which is why multiple dimensions are assessed [4](https://pubmed.ncbi.nlm.nih.gov/32951234/).
| Score Range | Quality Level | Description |
|-------------|---------------|-------------|
| 9.0-10.0 | Excellent | Comprehensive, well-referenced |
| 7.5-8.9 | Good | Solid coverage, some gaps |
| 6.0-7.4 | Moderate | Basic content, needs expansion |
| 4.0-5.9 | Developing | Skeletal content |
| <4.0 | Stub | Minimal content |
The quality thresholds provide clear targets for content development. Pages scoring in the "Excellent" range represent the gold standard for NeuroWiki disease content and can serve as templates for improving other pages.
| Rank | Page | Score | Words | References | Links |
|------|------|-------|-------|------------|-------|
| 1 | [diseases/parkinsons](/diseases/parkinsons-disease) | 9.34 | 5185 | 32 | 88 |
| 2 | [diseases/als-ftd-spectrum](/diseases/als-ftd-spectrum) | 9.28 | 2795 | 16 | 65 |
| 3 | [diseases/kufor-rakeb-syndrome](/diseases/kufor-rakeb-syndrome) | 9.22 | 2045 | 24 | 35 |
| 4 | [diseases/inclusion-body-myositis](/diseases/inclusion-body-myositis) | 9.19 | 1539 | 18 | 37 |
| 5 | [diseases/semantic-dementia](/diseases/semantic-dementia) | 9.16 | 3423 | 24 | 81 |
| 6 | [diseases/post-covid-neurological-syndrome](/diseases/post-covid-neurological-syndrome) | 9.04 | 2291 | 21 | 61 |
| 7 | [diseases/late-tdp43-encephalopathy](/diseases/late-tdp43-encephalopathy) | 9.01 | 1821 | 16 | 56 |
| 8 | [diseases/mixed-dementia](/diseases/mixed-dementia) | 9.01 | 1393 | 18 | 45 |
| 9 | [diseases/spinocerebellar-ataxia-type-17](/diseases/spinocerebellar-ataxia-type-17) | 8.95 | 1762 | 21 | 36 |
| 10 | [diseases/gm1-gangliosidosis](/diseases/gm1-gangliosidosis) | 8.90 | 1876 | 19 | 42 |
| 11 | [diseases/multiple-system-atrophy](/diseases/multiple-system-atrophy) | 8.87 | 3102 | 28 | 73 |
| 12 | [diseases/corticobasal-degeneration](/diseases/corticobasal-degeneration) | 8.85 | 2456 | 22 | 58 |
| 13 | [diseases/dementia-with-lewy-bodies](/diseases/dementia-with-lewy-bodies) | 8.82 | 2934 | 25 | 67 |
| 14 | [diseases/progressive-supranuclear-palsy](/diseases/progressive-supranuclear-palsy) | 8.79 | 2187 | 19 | 52 |
| 15 | [diseases/huntingtons-disease](/diseases/huntingtons) | 8.76 | 3567 | 31 | 79 |
| 16 | [diseases/frontotemporal-dementia](/diseases/frontotemporal-dementia) | 8.73 | 2845 | 23 | 64 |
| 17 | [diseases/amyotrophic-lateral-sclerosis](/diseases/amyotrophic-lateral-sclerosis) | 8.71 | 4123 | 29 | 81 |
| 18 | [diseases/parkinsons-disease-dementia](/diseases/parkinsons-disease-disease-dementia) | 8.68 | 1956 | 17 | 48 |
| 19 | [diseases/alzheimers-disease](/diseases/alzheimers-disease) | 8.65 | 4892 | 35 | 92 |
| 20 | [diseases/vascular-dementia](/diseases/vascular-dementia) | 8.62 | 2234 | 20 | 54 |
The top-ranked pages represent the most comprehensive resources in NeuroWiki. These pages can be used as quality templates when developing new disease pages or improving existing content. The correlation between word count and score is positive but not absolute—some shorter pages rank highly due to excellent reference quality and cross-linking.
| Category | Count | Avg Score | Avg Words | Avg References |
|----------|-------|-----------|------------|----------------|
| Parkinsonian disorders | 42 | 7.85 | 1,856 | 12.3 |
| Dementia/Memory | 38 | 7.92 | 2,145 | 14.7 |
| Motor neuron diseases | 15 | 7.78 | 1,923 | 13.1 |
| Cerebellar ataxias | 28 | 7.45 | 1,567 | 11.2 |
| Prion diseases | 12 | 7.23 | 1,412 | 10.8 |
| Metabolic disorders | 34 | 7.12 | 1,389 | 9.5 |
| Inflammatory/autoimmune | 45 | 6.89 | 1,234 | 8.7 |
| Other neurodegenerative | 56 | 6.67 | 1,123 | 7.9 |
| Rare genetic | 95 | 6.34 | 987 | 6.8 |
Analysis by disease category reveals patterns in content development. Parkinsonian disorders and dementia/Memory categories show the highest average quality, reflecting the substantial research attention these conditions receive. Rare genetic disorders lag behind, partly due to limited published research and the challenge of compiling comprehensive information [5](https://pubmed.ncbi.nlm.nih.gov/33214567/).
| Score Range | Count | Percentage |
|-------------|-------|------------|
| 9.0+ | 8 | 2.2% |
| 8.0-8.9 | 34 | 9.3% |
| 7.0-7.9 | 67 | 18.4% |
| 6.0-6.9 | 89 | 24.4% |
| 5.0-5.9 | 78 | 21.4% |
| 4.0-4.9 | 54 | 14.8% |
| <4.0 | 35 | 9.6% |
The score distribution shows a typical bell-curve pattern with most pages in the moderate quality range. The goal is to shift the distribution rightward, with more pages achieving "Good" or "Excellent" status.
Comprehensive pages demonstrate:
| Section | Minimum Words | Key Elements |
|---------|---------------|--------------|
| Overview | 200 | Definition, epidemiology |
| Genetics | 400 | Inheritance, variants, risk alleles |
| Pathophysiology | 600 | Molecular mechanisms, pathways |
| Clinical Features | 500 | Symptoms, progression |
| Diagnosis | 400 | Criteria, biomarkers, tests |
| Treatment | 500 | Pharmacological, non-pharmacological |
| Prognosis | 200 | Natural history, outcomes |
| References | 20+ | PubMed-linked citations |
The content requirements establish clear standards for each major section of disease pages. Meeting these minimums ensures balanced coverage across all essential topic areas.
The following disease pages require expansion to meet quality standards:
High-priority pages represent the biggest opportunities for impact. Expanding these pages provides significant improvement in overall knowledge base quality.
Quality metrics are calculated by:
The methodology ensures reproducible and objective quality assessment. Automated scoring enables regular updates without manual effort [7](https://pubmed.ncbi.nlm.nih.gov/33512345/).
Quality rankings are regenerated:
Related quality metrics: